Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HECT and RING finger families of E3 ubiquitin ligases at a glance
Meredith B. Metzger, Ventzislava A. Hristova, Allan M. Weissman
Journal of Cell Science (2012) Vol. 125, Iss. 3, pp. 531-537
Open Access | Times Cited: 582

Showing 1-25 of 582 citing articles:

Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Sue C. Bodine, Leslie M. Baehr
AJP Endocrinology and Metabolism (2014) Vol. 307, Iss. 6, pp. E469-E484
Open Access | Times Cited: 903
New insights into ubiquitin E3 ligase mechanism
Christopher Berndsen, Cynthia Wolberger
Nature Structural & Molecular Biology (2014) Vol. 21, Iss. 4, pp. 301-307
Closed Access | Times Cited: 645
The role of ubiquitination in tumorigenesis and targeted drug discovery
Lu Deng, Tong Meng, Lei Chen, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 535
Targeted protein degradation: elements of PROTAC design
Stacey-Lynn Paiva, Craig M. Crews
Current Opinion in Chemical Biology (2019) Vol. 50, pp. 111-119
Open Access | Times Cited: 481
The regulation of immune tolerance by FOXP3
Ling Lu, Joseph Barbi, Fan Pan
Nature reviews. Immunology (2017) Vol. 17, Iss. 11, pp. 703-717
Open Access | Times Cited: 458
The VCP/p97 system at a glance: connecting cellular function to disease pathogenesis
Hemmo Meyer, Conrad C. Weihl
Journal of Cell Science (2014)
Open Access | Times Cited: 405
MYC Degradation
Amy Farrell, Rosalie C. Sears
Cold Spring Harbor Perspectives in Medicine (2014) Vol. 4, Iss. 3, pp. a014365-a014365
Open Access | Times Cited: 394
Targeted Protein Degradation: from Chemical Biology to Drug Discovery
Philipp M. Cromm, Craig M. Crews
Cell chemical biology (2017) Vol. 24, Iss. 9, pp. 1181-1190
Open Access | Times Cited: 351
Disuse-induced muscle wasting
Sue C. Bodine
The International Journal of Biochemistry & Cell Biology (2013) Vol. 45, Iss. 10, pp. 2200-2208
Open Access | Times Cited: 340
SCF ubiquitin ligase-targeted therapies
Jeffrey R. Skaar, Julia K. Pagan, Michele Pagano
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 12, pp. 889-903
Open Access | Times Cited: 307
An apple MYB transcription factor regulates cold tolerance and anthocyanin accumulation and undergoes MIEL1‐mediated degradation
Jian‐Ping An, Xiao‐Fei Wang, Xiaowei Zhang, et al.
Plant Biotechnology Journal (2019) Vol. 18, Iss. 2, pp. 337-353
Open Access | Times Cited: 291
Mammalian HECT ubiquitin-protein ligases: Biological and pathophysiological aspects
Martin Scheffner, Sharad Kumar
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) Vol. 1843, Iss. 1, pp. 61-74
Open Access | Times Cited: 269
RBR E3 ubiquitin ligases: new structures, new insights, new questions
Donald E. Spratt, Helen Walden, Gary S. Shaw
Biochemical Journal (2014) Vol. 458, Iss. 3, pp. 421-437
Open Access | Times Cited: 266
Small-Molecule Modulation of Protein Homeostasis
George M. Burslem, Craig M. Crews
Chemical Reviews (2017) Vol. 117, Iss. 17, pp. 11269-11301
Closed Access | Times Cited: 255
Targeting the ubiquitin-proteasome pathway to overcome anti-cancer drug resistance
Silpa Narayanan, Chao‐Yun Cai, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2019) Vol. 48, pp. 100663-100663
Closed Access | Times Cited: 254
Current strategies for the design of PROTAC linkers: a critical review
Robert I. Troup, Charlene Fallan, Matthias G. J. Baud
Exploration of Targeted Anti-tumor Therapy (2020) Vol. 1, Iss. 5
Open Access | Times Cited: 251
Herpes Simplex Virus 1 Infection Induces Activation and Subsequent Inhibition of the IFI16 and NLRP3 Inflammasomes
Karen E. Johnson, Chikoti Leela, Bala Chandran
Journal of Virology (2013) Vol. 87, Iss. 9, pp. 5005-5018
Open Access | Times Cited: 248
The ubiquitin proteasome system — Implications for cell cycle control and the targeted treatment of cancer
Florian Bassermann, Ruth Eichner, Michele Pagano
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2013) Vol. 1843, Iss. 1, pp. 150-162
Open Access | Times Cited: 244
Versatile Roles of K63-Linked Ubiquitin Chains in Trafficking
Zoi Erpapazoglou, Olivier Walker, Rosine Haguenauer‐Tsapis
Cells (2014) Vol. 3, Iss. 4, pp. 1027-1088
Open Access | Times Cited: 195
Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
Shanique Alabi, Craig M. Crews
Journal of Biological Chemistry (2021) Vol. 296, pp. 100647-100647
Open Access | Times Cited: 189
Prey for the Proteasome: Targeted Protein Degradation—A Medicinal Chemist's Perspective
Laura M. Luh, U. Scheib, Katrin Juenemann, et al.
Angewandte Chemie International Edition (2020) Vol. 59, Iss. 36, pp. 15448-15466
Open Access | Times Cited: 152
Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors
Shiyao Chen, Yunqi Liu, Huchen Zhou
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4546-4546
Open Access | Times Cited: 104
Targeting the ubiquitin–proteasome system for cancer therapy
Min Shen, Sara M. Schmitt, Daniela Buac, et al.
Expert Opinion on Therapeutic Targets (2013) Vol. 17, Iss. 9, pp. 1091-1108
Open Access | Times Cited: 188
Mcl-1 Ubiquitination: Unique Regulation of an Essential Survival Protein
Barbara Mojsa, Irina Lassot, Solange Desagher
Cells (2014) Vol. 3, Iss. 2, pp. 418-437
Open Access | Times Cited: 167
Glucocorticoids and Skeletal Muscle
Sue C. Bodine, J. David Furlow
Advances in experimental medicine and biology (2015), pp. 145-176
Closed Access | Times Cited: 166
Page 1 - Next Page

Scroll to top